LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

AstraZeneca PLC ADR

Затворен

82.94 -0.01

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

82.94

Максимум

83.26

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+6.27 upside

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

AstraZeneca PLC ADR Графика

Свързани новини

25.07.2024 г., 09:17 ч. UTC

Печалби

AstraZeneca Raises Guidance After Results Beat Market Expectations -- Update

25.07.2024 г., 06:48 ч. UTC

Печалби

AstraZeneca Raises Guidance After Revenue, Earnings Beat Market Expectations

12.07.2024 г., 19:57 ч. UTC

Значими двигатели на пазара

Instil Bio Shares Surge Following Rental Agreement with AstraZeneca

5.09.2024 г., 13:00 ч. UTC

Топ новини

China Detains AstraZeneca Employees Over Alleged Transport of Unapproved Drug -- WSJ

29.07.2024 г., 10:30 ч. UTC

Топ новини

Big Pharma Rallies and Moves Past Obesity -- Heard on the Street -- WSJ

25.07.2024 г., 13:20 ч. UTC

Печалби

AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD

25.07.2024 г., 09:21 ч. UTC

Пазарно говорене
Печалби

AstraZeneca's Guidance Lift Is Conservative; Risks to Upside -- Market Talk

25.07.2024 г., 07:05 ч. UTC

Пазарно говорене
Печалби

AstraZeneca Guidance Raise Signals Portfolio Potential -- Market Talk

25.07.2024 г., 06:06 ч. UTC

Печалби

AstraZeneca Increased Interim Dividend by 7c to $1.00

25.07.2024 г., 06:04 ч. UTC

Печалби

AstraZeneca Had Seen Core EPS Grow by Low Double-Digit to Low Teens Percentage Range

25.07.2024 г., 06:04 ч. UTC

Печалби

AstraZeneca Had Seen Total Revenue Grow by Low Double-Digit to Low Teens Percentage Range

25.07.2024 г., 06:04 ч. UTC

Печалби

AstraZeneca Sees Core EPS Growth in 2024 by Mid Teens Percentage Range At Constant Currency

25.07.2024 г., 06:04 ч. UTC

Печалби

AstraZeneca Sees Total Revenue Growth in 2024 by Mid Teens Percentage Range At Constant Currency

25.07.2024 г., 06:03 ч. UTC

Печалби

AstraZeneca Raises 2024 View

25.07.2024 г., 06:02 ч. UTC

Печалби

AstraZeneca 2Q Revenue Consensus Was $12.7B

25.07.2024 г., 06:02 ч. UTC

Печалби

AstraZeneca 2Q Core EPS Consensus Was $1.95

25.07.2024 г., 06:00 ч. UTC

Печалби

AstraZeneca PLC 2Q Adj EPS $1.98

25.07.2024 г., 06:00 ч. UTC

Печалби

AstraZeneca PLC 2Q Pretax Pft $2.4B

25.07.2024 г., 06:00 ч. UTC

Печалби

AstraZeneca PLC 2Q Rev $12.94B

25.07.2024 г., 06:00 ч. UTC

Печалби

AstraZeneca PLC 2Q Oper Pft $2.75B

25.07.2024 г., 06:00 ч. UTC

Печалби

AstraZeneca PLC 2Q Net Pft $1.93B

25.07.2024 г., 06:00 ч. UTC

Печалби

AstraZeneca PLC 2Q EPS $1.24

15.07.2024 г., 06:04 ч. UTC

Придобивния, сливания и поглъщания

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

15.07.2024 г., 06:04 ч. UTC

Придобивния, сливания и поглъщания

AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone

15.07.2024 г., 06:02 ч. UTC

Придобивния, сливания и поглъщания

AstraZeneca: Acquisition Includes $800M Upfront at Deal Closing

15.07.2024 г., 06:02 ч. UTC

Придобивния, сливания и поглъщания

AstraZeneca: Amolyt Pharma's Total Consideration of Up to $1.05B

15.07.2024 г., 06:01 ч. UTC

Придобивния, сливания и поглъщания

AstraZeneca: Acquisition Bolsters Alexion Rare Disease Late-Stage Pipeline

15.07.2024 г., 06:00 ч. UTC

Придобивния, сливания и поглъщания

AstraZeneca Completes Acquisition of Amolyt Pharma

15.07.2024 г., 06:00 ч. UTC

Придобивния, сливания и поглъщания

AstraZeneca PLC Acquisition of Amolyt Pharma completed

15.07.2024 г., 06:00 ч. UTC

Придобивния, сливания и поглъщания

AstraZeneca PLC Acquisition of Amolyt Pharma completed

Сравнение с други в отрасъла

Ценова промяна

AstraZeneca PLC ADR Прогноза

Ценова цел

By TipRanks

6.27% нагоре

12-месечна прогноза

Среден 88.26 USD  6.27%

Висок 99 USD

Нисък 74 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за AstraZeneca PLC ADR през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

6 ratings

5

Купи

1

Задържане

0

Продай

Техническа оценка

By Trading Central

82.46 / 87.21Подкрепа & съпротива

Краткосрочен план

Very Strong Bearish Evidence

Средносрочен план

Bearish Evidence

Дългосрочен план

No Evidence